Key result
Pancreaticoduodenectomy successfully treats recurrent duodenal histiocytic sarcoma following initial segmental resection.
Why the study?
Histiocytic sarcoma is a rare malignant tumor whose characteristics are not well-understood due to limited reports on clinical presentation and treatment.
Case Report (n=1)
No
This is the first reported case of a duodenal primary histiocytic sarcoma with recurrence in the lymph node after primary resection, successfully treated with pancreaticoduodenectomy.
Answers are grounded in this paper and cite their sources.
May inform salvage surgery decisions in rare recurrences; leaves open optimal management strategies pending further evidence.
BACKGROUND: Histiocytic sarcoma is a rare malignant tumor that is similar in characteristics to a mature histiocyte/macrophage and is a relatively new disease entity. In approximately one-third of cases, the site of origin is a lymph node; development from the gastrointestinal tract, spleen, soft tissue, and skin has further been reported. The tumor characteristics are not well-understood as reports on its clinical presentation and treatment are limited. We report a case of duodenal primary histiocytic sarcoma. CASE PRESENTATION: An elevated lesion in the second part of the duodenum was detected in a 70-year-old woman during routine examination using upper gastrointestinal tract endoscopy. Blood biochemistry findings were normal for tumor markers. No abnormal findings were observed in the blood count and biochemical examination. Upper gastrointestinal endoscopy revealed a 20-mm elevated lesion with a slight depression in the center, opposite to the papilla of the descending duodenum. The biopsy showed erosions of the mucosal epithelium and inflammatory cell infiltration, but no evidence of malignancy. Ultrasound-guided endoscopy revealed an ischemic tumor of submucosal origin, and bowel biopsy suggested a histiocytic sarcoma. Distant metastasis and lymph node enlargement were absent on abdominal sonography, computed tomography, and magnetic resonance imaging. Duodenal segmental resection was performed. Immunostaining of the excised lesion was positive for CD68, CD163, CD4, CD5, CD15, and CD45 and negative for CD1a, CD21, CD34, MPO, and S-100 protein. Ki-67 positivity was approximately 20%. Based on these findings, the diagnosis of histiocytic sarcoma was confirmed. Ten months after the surgery, a lymph node recurrence in the dorsum of the pancreatic uncus was observed. No evidence of recurrence was found in any other part; hence, we performed pancreaticoduodenectomy. Pathological findings of the excised lymph node confirmed the recurrence of histiocytic sarcoma in the lymph node. CONCLUSIONS: This is the first reported case of a duodenal primary histiocytic sarcoma with recurrence in the lymph node after the primary resection. The patient was treated for recurrence by lymph node excision and pancreaticoduodenectomy.
No takes yet. Share an insight, caveat, or question.
Segami et al. (2022) conducted a case report in Histiocytic sarcoma of duodenal origin (n=1). Duodenal segmental resection and pancreaticoduodenectomy was evaluated on Patient survival and recurrence. A 70-year-old woman with primary duodenal histiocytic sarcoma experienced lymph node recurrence 10 months after segmental resection and was successfully treated with pancreaticoduodenectomy.
Synapse has enriched 10 related papers. Consider them for comparative context: